New Drug Gainer

This four-decade old company started out doing institutional business, selling anti-malarial drugs to the government. Only a decade ago, Ajanta changed its focus and started concentrating on branded formulations. In a heavily crowded market, Ajanta took the approach of launching new drugs in the country. Today, of the 175 drugs that it markets in the country, about 125 are first-time launches and new drug delivery systems (NDDS). That decision has paid off well. Branded formulations have grown

This article was originally published on May 07, 2015.